Chemo Pharma Laboratories Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|
Revenue | 0.63 | 0.30 | 0.25 |
Operating Expense | 0.02 | 0.05 | 0.09 |
Net Profit | 0.61 | 0.25 | -0.29 |
Net Profit Margin | 96.83 | 83.33 | -116.00 |
Earning Per Share | 4.07 | 1.64 | -1.94 |
EBIDTA | 0.61 | 0.25 | -0.02 |
Effective Tax Rate | TBA | TBA | 180.00 |
Particulars | Sep 2024 |
---|---|
Revenue | 0.63 |
Operating Expense | 0.02 |
Net Profit | 0.61 |
Net Profit Margin | 96.83 |
Earning Per Share | 4.07 |
EBIDTA | 0.61 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Total Revenue Annual | TBA | TBA | TBA |
Operating Expenses Annual | 0.19 | 0.21 | 0.41 |
Operating Profit Annual | 1.65 | 0.09 | 0.38 |
Interest Annual | TBA | TBA | TBA |
Depreciation | 0.01 | 0.01 | 0.02 |
Net Profit Annual | 1.20 | 0.05 | 0.56 |
Tax Annual | 0.44 | 0.03 | -0.20 |
Particulars | Mar 2024 |
---|---|
Total Revenue Annual | TBA |
Operating Expenses Annual | 0.19 |
Operating Profit Annual | 1.65 |
Interest Annual | TBA |
Depreciation | 0.01 |
Net Profit Annual | 1.20 |
Tax Annual | 0.44 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Cash Flow at the Beginning | 0.56 | 0.69 | 2.17 |
Cash Flow from Operations | 0.72 | -0.68 | -0.33 |
Cash Flow from Investing | -0.52 | 0.63 | 0.97 |
Cash Flow from Financing | -0.15 | -0.08 | -2.12 |
Cash Flow at the End | 0.61 | 0.56 | 0.69 |
Particulars | Mar 2024 |
---|---|
Cash Flow at the Beginning | 0.56 |
Cash Flow from Operations | 0.72 |
Cash Flow from Investing | -0.52 |
Cash Flow from Financing | -0.15 |
Cash Flow at the End | 0.61 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
PBDIT Margin (%) | TBA | TBA | TBA |
PBIT Margin (%) | TBA | TBA | TBA |
PBT Margin (%) | TBA | TBA | TBA |
Net PROFIT Margin (%) | TBA | TBA | TBA |
Return On Networth / Equity (%) | 9.84 | 0.43 | 3.37 |
Return On Networth /Employed (%) | 13.44 | 0.78 | 1.33 |
Return On Assets (%) | TBA | TBA | TBA |
Total Debt / Equity (X) | TBA | TBA | TBA |
Asset Turnover Ratio (%) | TBA | TBA | TBA |
Particulars | Mar 2024 |
---|---|
PBDIT Margin (%) | TBA |
PBIT Margin (%) | TBA |
PBT Margin (%) | TBA |
Net PROFIT Margin (%) | TBA |
Return On Networth / Equity (%) | 9.84 |
Return On Networth /Employed (%) | 13.44 |
Return On Assets (%) | TBA |
Total Debt / Equity (X) | TBA |
Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Fixed Assets Annual | 0.02 | 0.03 | 0.04 |
Total Current Assets Annual | 6.25 | 6.13 | 6.30 |
Non Current Assets Annual | 6.76 | 5.49 | 5.37 |
Total Shareholders Funds Annual | 12.80 | 11.60 | 11.55 |
Total Assets Annual | 13.02 | 11.62 | 11.66 |
Particulars | Mar 2024 |
---|---|
Fixed Assets Annual | 0.02 |
Total Current Assets Annual | 6.25 |
Non Current Assets Annual | 6.76 |
Total Shareholders Funds Annual | 12.80 |
Total Assets Annual | 13.02 |
No Data Availabe